Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 6/2010

01.12.2010 | Original Article

Phenylalanine loading in pediatric patients with dopa-responsive dystonia: revised test protocol and pediatric cutoff values

verfasst von: Thomas Opladen, Jürgen G. Okun, Peter Burgard, Nenad Blau, Georg F. Hoffmann

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The objectives of this study were to determine the value of phenylalanine (Phe) loading for diagnosing dopa-responsive dystonia (DRD) in children.

Methods

We investigated orally administered Phe loading tests (100 mg/kg) in seven patients with confirmed DRD and 17 pediatric patients with clinically suspected but excluded DRD. Results of Phe, tyrosine (Tyr), and biopterin from plasma and dried blood spot (DBS) analyses were correlated, and pediatric cutoff values established.

Results

The peak Phe concentration following a Phe load in the pediatric DRD population is lower than reported in adults. By using adult cutoff values and either Phe/Try ratios or biopterin concentrations only, false positive and false negative results are frequent. Only the combined analysis of the Phe/Tyr ratio and biopterin concentration is reliable in children. In children with DRD, dried blood Phe/Tyr ratio exceeded 4.6 (plasma Phe/Tyr ratio >5.4) after 2 h and biopterin concentration in dried blood remained below 16.2 nmol/L (plasma biopterin <14 nmol/L) 1 h after Phe challenge.

Conclusions

Phe loading is a useful tool for diagnosing DRD in children. Test duration can be reduced to only 2 h, and specific pediatric cutoff values need to be applied. Simultaneous measurements of the Phe/Tyr ratio and biopterin in plasma or DBS are essential in pediatric patients.
Literatur
Zurück zum Zitat Segawa M, Nomura Y, Nishiyama N (2003) Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 54(Suppl 6):S32–S45CrossRefPubMed Segawa M, Nomura Y, Nishiyama N (2003) Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 54(Suppl 6):S32–S45CrossRefPubMed
Zurück zum Zitat Thöny B, Auerbach G, Blau N (2000) Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 347(Pt 1):1–16CrossRefPubMed Thöny B, Auerbach G, Blau N (2000) Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 347(Pt 1):1–16CrossRefPubMed
Zurück zum Zitat Nygaard TG (1993) Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis. Adv Neurol 60:577–585PubMed Nygaard TG (1993) Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis. Adv Neurol 60:577–585PubMed
Zurück zum Zitat Grimes DA, Barclay CL, Duff J, Furukawa Y, Lang AE (2002) Phenocopies in a large GCH1 mutation positive family with dopa responsive dystonia: confusing the picture? J Neurol Neurosurg Psychiatry 72:801–804CrossRefPubMed Grimes DA, Barclay CL, Duff J, Furukawa Y, Lang AE (2002) Phenocopies in a large GCH1 mutation positive family with dopa responsive dystonia: confusing the picture? J Neurol Neurosurg Psychiatry 72:801–804CrossRefPubMed
Zurück zum Zitat Bandmann O, Valente EM, Holmans P et al (1998) Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol 44:649–656CrossRefPubMed Bandmann O, Valente EM, Holmans P et al (1998) Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol 44:649–656CrossRefPubMed
Zurück zum Zitat Blau N, Bonafe L, Thöny B (2001) Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab 74:172–185CrossRefPubMed Blau N, Bonafe L, Thöny B (2001) Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab 74:172–185CrossRefPubMed
Zurück zum Zitat Hyland K, Fryburg JS, Wilson WG et al (1997) Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test. Neurology 48:1290–1297PubMed Hyland K, Fryburg JS, Wilson WG et al (1997) Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test. Neurology 48:1290–1297PubMed
Zurück zum Zitat Bandmann O, Goertz M, Zschocke J et al (2003) The phenylalanine loading test in the differential diagnosis of dystonia. Neurology 60:700–702PubMed Bandmann O, Goertz M, Zschocke J et al (2003) The phenylalanine loading test in the differential diagnosis of dystonia. Neurology 60:700–702PubMed
Zurück zum Zitat Saunders-Pullmann R, Blau N, Hyland K et al (2004) Phenyalanine loading as a diagnostic test for DRD: interpreting the utility of the test. Mol Genet Metab 83:207–212CrossRef Saunders-Pullmann R, Blau N, Hyland K et al (2004) Phenyalanine loading as a diagnostic test for DRD: interpreting the utility of the test. Mol Genet Metab 83:207–212CrossRef
Zurück zum Zitat Lopez-Laso E, Ormazabal A, Camino R et al (2006) Oral phenylalanine loading test for the diagnosis of dominant guanosine triphosphate cyclohydrolase 1 deficiency. Clin Biochem 39:893–897CrossRefPubMed Lopez-Laso E, Ormazabal A, Camino R et al (2006) Oral phenylalanine loading test for the diagnosis of dominant guanosine triphosphate cyclohydrolase 1 deficiency. Clin Biochem 39:893–897CrossRefPubMed
Zurück zum Zitat Schulze A, Lindner M, Kohlmuller D, Olgemoller K, Mayatepek E, Hoffmann GF (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111:1399–1406CrossRefPubMed Schulze A, Lindner M, Kohlmuller D, Olgemoller K, Mayatepek E, Hoffmann GF (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111:1399–1406CrossRefPubMed
Zurück zum Zitat Blau N, Thöny B (2008) Pterins and related enzymes. In: Blau N, Duran M, Gibson KM (eds) Laboratory guide to the methods in biochemical genetics. Springer-Verlag, Heidelberg, Berlin, pp 665–702CrossRef Blau N, Thöny B (2008) Pterins and related enzymes. In: Blau N, Duran M, Gibson KM (eds) Laboratory guide to the methods in biochemical genetics. Springer-Verlag, Heidelberg, Berlin, pp 665–702CrossRef
Zurück zum Zitat Zurflüh MR, Giovannini M, Fiori L et al (2005) Screening for tetrahydrobiopterin deficiencies using dried blood spots on filter paper. Mol Genet Metab 86(Suppl 1):S96–S103CrossRefPubMed Zurflüh MR, Giovannini M, Fiori L et al (2005) Screening for tetrahydrobiopterin deficiencies using dried blood spots on filter paper. Mol Genet Metab 86(Suppl 1):S96–S103CrossRefPubMed
Zurück zum Zitat Blau N, Duran M, Blaskovics Me (2003) In: Physician's Guide to Laboratory Diagnosis of Metabolic Diseases, Chapter 2, 2nd edn. Springer, London, Berlin, pp. 89-106 Blau N, Duran M, Blaskovics Me (2003) In: Physician's Guide to Laboratory Diagnosis of Metabolic Diseases, Chapter 2, 2nd edn. Springer, London, Berlin, pp. 89-106
Zurück zum Zitat Bonafe L, Thony B, Leimbacher W, Kierat L, Blau N (2001) Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts. Clin Chem 47:477–485PubMed Bonafe L, Thony B, Leimbacher W, Kierat L, Blau N (2001) Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts. Clin Chem 47:477–485PubMed
Metadaten
Titel
Phenylalanine loading in pediatric patients with dopa-responsive dystonia: revised test protocol and pediatric cutoff values
verfasst von
Thomas Opladen
Jürgen G. Okun
Peter Burgard
Nenad Blau
Georg F. Hoffmann
Publikationsdatum
01.12.2010
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 6/2010
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9164-9

Weitere Artikel der Ausgabe 6/2010

Journal of Inherited Metabolic Disease 6/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.